FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891860800> ?p ?o ?g. }

• W2891860800 endingPage "e1162" @default.
• W2891860800 startingPage "e1156" @default.
• W2891860800 abstract "The A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) trial has received fierce criticism, including considerable selection bias, poor generalizability, questionable clinical practices (only 15.8% underwent surgical resection, the gold standard for arteriovenous malformation [AVM] treatment), and short follow-up (33 months) for a disease process that carries a life-long risk. In this study, we sought to present our own experience treating unruptured brain AVMs to provide supporting evidence of the ARUBA trial criticism. All cases of treated brain AVMs from 2004 to 2017 at our institution were retrospectively reviewed and included in the analysis if they met ARUBA trial inclusion criteria. The primary outcome was symptomatic stroke or death. Secondary outcomes included AVM obliteration, long-term clinical impairment (modified Rankin Scale score >1), and new major or minor postoperative deficit. Of the 245 reviewed cases, 86 met the ARUBA trial criteria. Treatment included microsurgical resection alone (2.3%), preoperative embolization followed by microsurgical resection (62.8%), stereotactic radiosurgery alone (10.5%), embolization followed by stereotactic radiosurgery (15.1%), and embolization alone (9.3%). The primary outcome was met in 8.3%, new perioperative major and minor complications occurred in 5.8% and 12.8%, and long-term clinical impairment in 4.5%. AVM obliteration was observed in 92.4% overall and in 100% of patients who underwent surgical resection. The criticism of the ARUBA trial is warranted, as our study found that treatment of unruptured brain AVMs has an acceptable safety profile when approached in a multidisciplinary manner at an experienced institution, using surgical resection as the primary treatment modality when applicable." @default.
• W2891860800 created "2018-09-27" @default.
• W2891860800 creator A5020186797 @default.
• W2891860800 creator A5022980737 @default.
• W2891860800 creator A5030104317 @default.
• W2891860800 creator A5034332264 @default.
• W2891860800 creator A5043783211 @default.
• W2891860800 creator A5054978430 @default.
• W2891860800 creator A5080490911 @default.
• W2891860800 creator A5087098119 @default.
• W2891860800 creator A5088751787 @default.
• W2891860800 date "2018-12-01" @default.
• W2891860800 modified "2023-10-11" @default.
• W2891860800 title "Treatment of Unruptured Brain Arteriovenous Malformations: A Single-Center Experience of 86 Patients and a Critique of the A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) Trial" @default.
• W2891860800 cites W1966390245 @default.
• W2891860800 cites W1972894106 @default.
• W2891860800 cites W1977987454 @default.
• W2891860800 cites W1982437710 @default.
• W2891860800 cites W1985758093 @default.
• W2891860800 cites W1993703345 @default.
• W2891860800 cites W2002945758 @default.
• W2891860800 cites W2011330553 @default.
• W2891860800 cites W2033255474 @default.
• W2891860800 cites W2059142743 @default.
• W2891860800 cites W2066788634 @default.
• W2891860800 cites W2091025090 @default.
• W2891860800 cites W2123067896 @default.
• W2891860800 cites W2130774572 @default.
• W2891860800 cites W2131896620 @default.
• W2891860800 cites W2171301714 @default.
• W2891860800 cites W2192104003 @default.
• W2891860800 cites W2357760782 @default.
• W2891860800 cites W2466299363 @default.
• W2891860800 cites W2511249840 @default.
• W2891860800 cites W2549451262 @default.
• W2891860800 cites W2613030232 @default.
• W2891860800 cites W4249616895 @default.
• W2891860800 doi "https://doi.org/10.1016/j.wneu.2018.09.025" @default.
• W2891860800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30218805" @default.
• W2891860800 hasPublicationYear "2018" @default.
• W2891860800 type Work @default.
• W2891860800 sameAs 2891860800 @default.
• W2891860800 citedByCount "30" @default.
• W2891860800 countsByYear W28918608002019 @default.
• W2891860800 countsByYear W28918608002020 @default.
• W2891860800 countsByYear W28918608002021 @default.
• W2891860800 countsByYear W28918608002022 @default.
• W2891860800 countsByYear W28918608002023 @default.
• W2891860800 crossrefType "journal-article" @default.
• W2891860800 hasAuthorship W2891860800A5020186797 @default.
• W2891860800 hasAuthorship W2891860800A5022980737 @default.
• W2891860800 hasAuthorship W2891860800A5030104317 @default.
• W2891860800 hasAuthorship W2891860800A5034332264 @default.
• W2891860800 hasAuthorship W2891860800A5043783211 @default.
• W2891860800 hasAuthorship W2891860800A5054978430 @default.
• W2891860800 hasAuthorship W2891860800A5080490911 @default.
• W2891860800 hasAuthorship W2891860800A5087098119 @default.
• W2891860800 hasAuthorship W2891860800A5088751787 @default.
• W2891860800 hasConcept C126322002 @default.
• W2891860800 hasConcept C126838900 @default.
• W2891860800 hasConcept C127413603 @default.
• W2891860800 hasConcept C141071460 @default.
• W2891860800 hasConcept C168563851 @default.
• W2891860800 hasConcept C2776035437 @default.
• W2891860800 hasConcept C2778749279 @default.
• W2891860800 hasConcept C2779603958 @default.
• W2891860800 hasConcept C2780387249 @default.
• W2891860800 hasConcept C2780643987 @default.
• W2891860800 hasConcept C2780645631 @default.
• W2891860800 hasConcept C2780931571 @default.
• W2891860800 hasConcept C2781437307 @default.
• W2891860800 hasConcept C2910939485 @default.
• W2891860800 hasConcept C3020199598 @default.
• W2891860800 hasConcept C31174226 @default.
• W2891860800 hasConcept C40993552 @default.
• W2891860800 hasConcept C509974204 @default.
• W2891860800 hasConcept C535046627 @default.
• W2891860800 hasConcept C541997718 @default.
• W2891860800 hasConcept C71924100 @default.
• W2891860800 hasConcept C78519656 @default.
• W2891860800 hasConceptScore W2891860800C126322002 @default.
• W2891860800 hasConceptScore W2891860800C126838900 @default.
• W2891860800 hasConceptScore W2891860800C127413603 @default.
• W2891860800 hasConceptScore W2891860800C141071460 @default.
• W2891860800 hasConceptScore W2891860800C168563851 @default.
• W2891860800 hasConceptScore W2891860800C2776035437 @default.
• W2891860800 hasConceptScore W2891860800C2778749279 @default.
• W2891860800 hasConceptScore W2891860800C2779603958 @default.
• W2891860800 hasConceptScore W2891860800C2780387249 @default.
• W2891860800 hasConceptScore W2891860800C2780643987 @default.
• W2891860800 hasConceptScore W2891860800C2780645631 @default.
• W2891860800 hasConceptScore W2891860800C2780931571 @default.
• W2891860800 hasConceptScore W2891860800C2781437307 @default.
• W2891860800 hasConceptScore W2891860800C2910939485 @default.
• W2891860800 hasConceptScore W2891860800C3020199598 @default.
• W2891860800 hasConceptScore W2891860800C31174226 @default.
• W2891860800 hasConceptScore W2891860800C40993552 @default.
• W2891860800 hasConceptScore W2891860800C509974204 @default.

• next